These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 23882708)

  • 21. The association between skin collagen glucosepane and past progression of microvascular and neuropathic complications in type 1 diabetes.
    Monnier VM; Sell DR; Strauch C; Sun W; Lachin JM; Cleary PA; Genuth S;
    J Diabetes Complications; 2013; 27(2):141-9. PubMed ID: 23153673
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Kidney disease and related findings in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study.
    de Boer IH;
    Diabetes Care; 2014; 37(1):24-30. PubMed ID: 24356594
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Advanced glycation end-products and methionine sulphoxide in skin collagen of patients with type 1 diabetes.
    Yu Y; Thorpe SR; Jenkins AJ; Shaw JN; Sochaski MA; McGee D; Aston CE; Orchard TJ; Silvers N; Peng YG; McKnight JA; Baynes JW; Lyons TJ;
    Diabetologia; 2006 Oct; 49(10):2488-98. PubMed ID: 16955213
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of markers of glycaemic control in diabetic patients with chronic kidney disease using continuous glucose monitoring.
    Vos FE; Schollum JB; Coulter CV; Manning PJ; Duffull SB; Walker RJ
    Nephrology (Carlton); 2012 Feb; 17(2):182-8. PubMed ID: 21883672
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of prior intensive versus conventional therapy and history of glycemia on cardiac function in type 1 diabetes in the DCCT/EDIC.
    Genuth SM; Backlund JY; Bayless M; Bluemke DA; Cleary PA; Crandall J; Lachin JM; Lima JA; Miao C; Turkbey EB;
    Diabetes; 2013 Oct; 62(10):3561-9. PubMed ID: 23520132
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Skin intrinsic fluorescence correlates with autonomic and distal symmetrical polyneuropathy in individuals with type 1 diabetes.
    Conway BN; Aroda VR; Maynard JD; Matter N; Fernandez S; Ratner RE; Orchard TJ
    Diabetes Care; 2011 Apr; 34(4):1000-5. PubMed ID: 21307380
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Accumulation of advanced glycation end products in the skin is accelerated in relation to insulin resistance in people with Type 1 diabetes mellitus.
    Uruska A; Gandecka A; Araszkiewicz A; Zozulinska-Ziolkiewicz D
    Diabet Med; 2019 May; 36(5):620-625. PubMed ID: 30706538
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Skin autofluorescence reflects integration of past long-term glycemic control in patients with type 1 diabetes.
    Sugisawa E; Miura J; Iwamoto Y; Uchigata Y
    Diabetes Care; 2013 Aug; 36(8):2339-45. PubMed ID: 23579177
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of intensive glycemic treatment on coronary artery calcification in type 1 diabetic participants of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study.
    Cleary PA; Orchard TJ; Genuth S; Wong ND; Detrano R; Backlund JY; Zinman B; Jacobson A; Sun W; Lachin JM; Nathan DM;
    Diabetes; 2006 Dec; 55(12):3556-65. PubMed ID: 17130504
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Severe hypoglycemia and coronary artery calcification during the diabetes control and complications trial/epidemiology of diabetes interventions and complications (DCCT/EDIC) study.
    Fährmann ER; Adkins L; Loader CJ; Han H; Rice KM; Denvir J; Driscoll HK
    Diabetes Res Clin Pract; 2015 Feb; 107(2):280-9. PubMed ID: 25467622
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma advanced glycation end products and the subsequent risk of microvascular complications in type 1 diabetes in the DCCT/EDIC.
    Monnier VM; Sell DR; Gao X; Genuth SM; Lachin JM; Bebu I;
    BMJ Open Diabetes Res Care; 2022 Jan; 10(1):. PubMed ID: 35058313
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Advanced glycation end products are associated with arterial stiffness in type 1 diabetes.
    Llauradó G; Ceperuelo-Mallafré V; Vilardell C; Simó R; Gil P; Cano A; Vendrell J; González-Clemente JM
    J Endocrinol; 2014 Jun; 221(3):405-13. PubMed ID: 24681829
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Distinct associations of HbA1c and the urinary excretion of pentosidine, an advanced glycosylation end-product, with markers of endothelial function in insulin-dependent diabetes mellitus.
    Smulders RA; Stehouwer CD; Schalkwijk CG; Donker AJ; van Hinsbergh VW; TeKoppele JM
    Thromb Haemost; 1998 Jul; 80(1):52-7. PubMed ID: 9684785
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The relationship of blood glucose with cardiovascular disease is mediated over time by traditional risk factors in type 1 diabetes: the DCCT/EDIC study.
    Bebu I; Braffett BH; Pop-Busui R; Orchard TJ; Nathan DM; Lachin JM;
    Diabetologia; 2017 Oct; 60(10):2084-2091. PubMed ID: 28711972
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Skin autofluorescence and complications of diabetes: does ethnic background or skin color matter?
    Ahdi M; Gerdes VE; Graaff R; Kuipers S; Smit AJ; Meesters EW
    Diabetes Technol Ther; 2015 Feb; 17(2):88-95. PubMed ID: 25562390
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glycaemic control and risk of incident urinary incontinence in women with Type 1 diabetes: results from the Diabetes Control and Complications Trial and Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) study.
    Lenherr SM; Clemens JQ; Braffett BH; Dunn RL; Cleary PA; Kim C; Herman WH; Hotaling JM; Jacobson AM; Brown JS; Wessells H; Sarma AV;
    Diabet Med; 2016 Nov; 33(11):1528-1535. PubMed ID: 27028025
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Progression of skin autofluorescence of AGEs over 4 years in patients with type 1 diabetes.
    Rajaobelina K; Helmer C; Vélayoudom-Céphise FL; Nov S; Farges B; Pupier E; Blanco L; Hugo M; Gin H; Rigalleau V
    Diabetes Metab Res Rev; 2017 Oct; 33(7):. PubMed ID: 28719154
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Skin intrinsic fluorescence scores are a predictor of all-cause mortality risk in type 1 diabetes: The Epidemiology of Diabetes Complications study.
    Tomaszewski EL; Orchard TJ; Hawkins M; Conway BN; Buchanich JM; Maynard J; Songer T; Costacou T
    J Diabetes Complications; 2021 Feb; 35(2):107770. PubMed ID: 33168396
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Refractive Error and Retinopathy Outcomes in Type 1 Diabetes: The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study.
    Hainsworth DP; Gao X; Bebu I; Das A; Olmos de Koo L; Barkmeier AJ; Tamborlane W; Lachin JM; Aiello LP;
    Ophthalmology; 2021 Apr; 128(4):554-560. PubMed ID: 32941962
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of advanced glycation end products and chronic kidney disease with macroangiopathy in type 2 diabetes.
    Rigalleau V; Cougnard-Gregoire A; Nov S; Gonzalez C; Maury E; Lorrain S; Gin H; Barberger-Gateau P
    J Diabetes Complications; 2015 Mar; 29(2):270-4. PubMed ID: 25468311
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.